How to Buy Avid Bioservices Stock
Avid Bioservices Inc
Avid Bioservices, Inc. , a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture.
Avid Bioservices stock last closed at $8.20, up 6.91% from the previous day, and has decreased 53.38% in one year. It has underperformed other stocks in the Biotechnology industry by 0.35 percentage points. Avid Bioservices stock is currently +101.42% from its 52-week low of $4.07, and -56.52% from its 52-week high of $18.86.
There are currently 63.48M shares of CDMO outstanding. The market value of CDMO is $520.53M. In the last 24 hours, 1.83M CDMO shares were traded.
How to Buy Avid Bioservices Stock
Wondering how to invest in Avid Bioservices stock? Here's how.
- Decide where to buy Avid Bioservices stock: You need to choose a stock brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you decide where to buy Avid Bioservices stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Put funds into your brokerage account: Pick your method of payment and add your information.
- Analyze Avid Bioservices stock: The Avid Bioservices ticker symbol is CDMO. Is Avid Bioservices stock a good investment? Should you buy shares of CDMO? How do CDMO's underlying business fundamentals look? Do top analysts think Avid Bioservices is a good buy? Why has CDMO's stock price moved recently? (Hint: Our stock analysis website can help you figure out if CDMO is a good stock to buy).
- Place your CDMO trade: Decide if you will purchase CDMO shares at the current market price or use a limit order to buy CDMO shares at a given price.
- Keep an eye on your investment in CDMO: Create a watchlist to the latest updates on your position in Avid Bioservices stock.
Step 1: Decide where to buy Avid Bioservices stock
You need a brokerage account in order to access the NASDAQ market and buy CDMO stock.
Our preferred brokerage: eToro
Based on our research, eToro is the best brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global financial markets: From Technology to Energy, New York to Hong Kong — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by signing up for an account with eToro today.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked your brokerage, the next step is to fill out some personal info so you can invest in CDMO stock today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to create your new brokerage account.
- Send your info by hitting the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've opened your account on the best stock buying app, your next step is to transfer the money for your investment:
Watch the tutorial below for more details transferring money into your brokerage account.
Step 4: Analyze Avid Bioservices stock
Once you have chosen the best place to buy Avid Bioservices stock, it's crucial to research their stock prior to buying, so you can wrap your head around the risk as well as the upside.
Avid Bioservices shares at a glance
Fundamentals of CDMO
WallStreetZen was designed to help everyday investors do more accurate fundamental analysis in less time.
You can view all of the due diligence checks on CDMO's stock page.
Is CDMO stock undervalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge CDMO's intrinsic value.
Using relative valuations ratios:
- CDMO may be undervalued based on its P/B ratio of 2.89x, relative to Biotechnology industry P/B ratio of 5.99x
You can do more valuation analysis on CDMO's stock here.
A look at CDMO Cashflows and Balance Sheet
Passed Financial Due Diligence Checks:
- CDMO has $30.71M in cash and short term investments. This is sufficient to cover its annual cash burn of $38.50M.
- There are more short-term assets than long-term liabilities on the CDMO balance sheet.
Failed Financial Due Diligence Checks:
- There are more short-term liabilities than short-term assets on the CDMO balance sheet.
- CDMO profit margin has gone down from 82.6% to -13.2% in the past year.
- Total CDMO debt is higher than 5 years ago, relative to shareholder equity.
- CDMO has cash burn of 38495000. It does not have enough cash and short-term investments to cover this.
- CDMO has a relatively high debt to equity ratio of 1.53.
Do analysts think it's a good time to buy Avid Bioservices stock
Out of 4 Equities analysts who research CDMO, the consensus analyst rating on CDMO is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are forecasting on the Avid Bioservices stock forecast page.
CDMO Momentum
CDMO Growth Numbers
Last year, CDMO revenue was $136.74M. Over the last five year, CDMO's revenue has increased by 25.75% per year. This was slower than the Biotechnology industry average of 29.57%.
Learn more about CDMO's earnings and revenue performance here.
Who is buying/selling CDMO?
Over the past 12 months, executives and large shareholders at CDMO have sold more shares than they have bought.
Nicholas Stewart Green, President CEO of CDMO, was the latest CDMO insider to sell. They sold $87,027.04 worth of CDMO shares on Apr 30, 2024.
Learn more about who owns CDMO shares here.
Can I rely on CDMO as an income stream?
No, Avid Bioservices doesn't provide an income stream by paying out dividends.
CDMO Social Trading Data
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Place your CDMO trade
You have two main options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are generally fine for most investors. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a given dollar amount, use a limit order.
Click the Open Trade button and your broker will place your order.
If you want more help buying stocks on eToro, watch the helpful video below:
Step 6: Keep an eye on your investment in CDMO
Now that you own some CDMO stock, you'll want to keep up with your new company.
Add CDMO to a watchlist to get notified of the latest news about your CDMO stock.
CDMO Feed
How to Buy Stock in Avid Bioservices
To summarize, here are the 6 steps for buying Avid Bioservices stock:
- Decide where to buy Avid Bioservices stock
- Create your brokerage account
- Put funds into your brokerage account
- Analyze Avid Bioservices stock
- Place your CDMO trade
- Keep an eye on your investment in CDMO
If you require a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to monitor your investment in Avid Bioservices, create a watchlist on WallStreetZen today.
More Content You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.